Prostate Cancer in Transplant Receivers—A Narrative Review on Oncological Outcomes

Prostate cancer (PCa) is a low tumor mutational burden (TMB) cancer with a poor response to immunotherapy. Nonetheless, immunotherapy can be useful, especially in metastatic castration-resistant PCa (mCRPC). Increased cytotoxic T lymphocytes (CTLs) density is correlated with a shorter overall surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanusz, Karolina, Domański, Piotr, Strojec, Kacper, Zapała, Piotr, Zapała, Łukasz, Radziszewski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669184/
https://www.ncbi.nlm.nih.gov/pubmed/38001942
http://dx.doi.org/10.3390/biomedicines11112941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669184/
https://www.ncbi.nlm.nih.gov/pubmed/38001942
http://dx.doi.org/10.3390/biomedicines11112941

Ejemplares similares